SCHEMBL20140095

SCHEMBL20140095

Cc1cccc(C2=CCN(C(=O)O)CC2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.54
DRD4 P21917 7/20 0.54
DRD2 P14416 6/20 0.54
KCNH2 Q12809 2/20 0.47
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
GRM5 P41594 3/20 0.41
GRM1 Q13255 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CCR1 P32246 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20140921 0.86 HTR1A (0.45) HTR1ADRD4DRD2KCNH2USP2
SCHEMBL29924281 0.84 ALDH1A1 (0.45) HTR1ADRD4DRD2KCNH2ALDH1A1
SCHEMBL29668566 0.83 ALDH1A1 (0.41) HTR1ADRD4DRD2KCNH2HPGD
SCHEMBL439379 0.83 ALDH1A1 (0.41) HTR1ADRD4DRD2KCNH2LMNA
SCHEMBL29924612 0.83 ALDH1A1 (0.41) HTR1ADRD4DRD2KCNH2LMNA
SCHEMBL16422282 0.83 ALDH1A1 (0.41) HTR1ADRD4DRD2KCNH2LMNA
SCHEMBL14761667 0.83 ALDH1A1 (0.42) HTR1ADRD4DRD2KCNH2LMNA
SCHEMBL26117408 0.83 HTR1A (0.48) HTR1ADRD4DRD2KCNH2ALDH1A1
SCHEMBL16422799 0.83 GRM1 (0.41) HTR1ADRD4DRD2KCNH2ALDH1A1
SCHEMBL16544582 0.82 GRM5 (0.59) HTR1ADRD4DRD2GRM5GRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed